Isopropyl-β-D-Thiogalactoside Market In Global
IPTG is an analog of galactose that is non-metabolizable and inactivates the lac repressor to ind ... Read More
RNase A is an endoribonuclease that specifically hydrolyzes RNA 3´ of pyrimidine residues and cleaves the phosphodiester linkage to the adjacent nucleotide. RNase A is used to remove RNA during procedures for the isolation of plasmid and genomic DNA.
This report contains market size and forecasts of RNase A in global, including the following market information:
Global RNase A Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global RNase A Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five RNase A companies in 2021 (%)
The global RNase A market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
RNase A In Solution Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNase A include Thermo Fisher Scientific, QIAGEN, Merck, Beyotime, NEB, Promega, Canvax, Worthington Biochemical and Carl ROTH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNase A manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNase A Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global RNase A Market Segment Percentages, by Type, 2021 (%)
RNase A In Solution
RNase A In Lyophilized Powde
Global RNase A Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global RNase A Market Segment Percentages, by Application, 2021 (%)
Nucleic Acid Purification
Synthetic Biology
Global RNase A Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global RNase A Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNase A revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies RNase A revenues share in global market, 2021 (%)
Key companies RNase A sales in global market, 2017-2022 (Estimated), (Kg)
Key companies RNase A sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
QIAGEN
Merck
Beyotime
NEB
Promega
Canvax
Worthington Biochemical
Carl ROTH
Bio Basic
AG Scientific
Jena Bioscience
Yeasen Biotech
Gold Biotechnology
Geneaid
Omega Bio-Tek
Rockland Immunochemicals
BioVision
LGC
IPTG is an analog of galactose that is non-metabolizable and inactivates the lac repressor to ind ... Read More
Dihydroethidium is a cell-permeable blue fluorescent dye that upon entering cells interacts with ... Read More
Edu is a thymidine analog that can be incorporated into replicating DNA for detection of cell rol ... Read More
A integreated vacuum centrifugal concentrator concentrates solutes from a liquid sample into a dr ... Read More